Gamma-hydroxybutyrate (GHB also known as 4-hydroxybutyric acid) is an endogenous metabolite, present in most mammalian tissues at nanomolar concentrations, that has been hypothesized to have a role as a neurotransmitter and is a metabolite of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It may be employed clinically as an anaesthetic and hypnotic agent, however GHB is used illicitly both as a steroid alternative for body building and also as a ‘club’ or ‘date rape’ drug due to its hypnotic effect and lack of colour or odour. Euphoria, increased sex drive, and tranquillity are reported positive effects of GHB abuse. Negative effects may include sweating, loss of consciousness (reported by 69 percent of users), nausea, hallucinations, amnesia, and coma, among other adverse effects. Several metabolic precursors to GHB, such as gamma-butyrolactone (GBL) and 1,4-butanediol, and GBL analogues such as gamma-valerolactone (GVL), have also been subject to abuse. GHB, either as the primary agent or as a metabolite of GBL or 1,4-butanediol, may therefore be measured when there is a question as to whether a drink may have been spiked. However, GHB is metabolised quickly with the drug undetectable in urine 12 hours post dose. This assay will not detect GVL use.
GHB is cleared from the body very quickly and is often undetectable in urine 12 h post dose. Please take samples (urine and blood if possible) as soon as possible following potential exposure.
Analysed by GC-MS.
Gamma-hydroxybutyrate (GHB) has been employed as an anaesthetic agent but is now more widely used and abused for its sedative properties. Toxic effects (euphoria, dizziness and unconsciousness) usually occur around 15 minutes post ingestion and last on average for about 3 hours. It has been found that blood concentrations above 260 mg/L were associated with deep sleep, 156 – 260 mg/L with moderate sleep, 52 – 156 mg/L with light sleep and levels less than 52 mg/L with wakefulness.
Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018
HTA licence number is 12366
Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further information contact Louise Fallon, Quality Manager, 0121 424 1235